Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
82.29
Dollar change
+0.91
Percentage change
1.12
%
IndexS&P 500 P/E29.83 EPS (ttm)2.76 Insider Own0.07% Shs Outstand1.33B Perf Week-4.22%
Market Cap109.27B Forward P/E14.12 EPS next Y5.83 Insider Trans-3.78% Shs Float1.33B Perf Month3.84%
Income3.68B PEG6.78 EPS next Q1.20 Inst Own85.75% Short Float1.16% Perf Quarter-1.65%
Sales32.36B P/S3.38 EPS this Y4.73% Inst Trans1.45% Short Ratio2.54 Perf Half Y5.00%
Book/sh38.29 P/B2.15 EPS next Y7.05% ROA4.06% Short Interest15.33M Perf Year-5.94%
Cash/sh6.03 P/C13.65 EPS next 5Y4.40% ROE7.23% 52W Range68.84 - 91.00 Perf YTD-0.11%
Dividend Est.2.73 (3.31%) P/FCF21.01 EPS past 5Y-4.14% ROI4.96% 52W High-9.57% Beta0.84
Dividend TTM2.76 (3.35%) Quick Ratio1.55 Sales past 5Y1.24% Gross Margin67.86% 52W Low19.54% ATR (14)1.40
Dividend Ex-DateJun 28, 2024 Current Ratio2.03 EPS Y/Y TTM-2.06% Oper. Margin18.80% RSI (14)46.89 Volatility1.83% 1.45%
Employees95000 Debt/Eq0.50 Sales Y/Y TTM3.64% Profit Margin11.36% Recom2.35 Target Price93.83
Option/ShortYes / Yes LT Debt/Eq0.48 EPS Q/Q-44.61% Payout100.00% Rel Volume1.45 Prev Close81.38
Sales Surprise1.64% EPS Surprise0.63% Sales Q/Q0.53% EarningsMay 23 BMO Avg Volume6.04M Price82.29
SMA20-0.62% SMA50-0.59% SMA2001.40% Trades Volume8,732,202 Change1.12%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Mar-29-23Downgrade UBS Buy → Sell $127 → $79
Jan-09-23Downgrade RBC Capital Mkts Outperform → Sector Perform $102 → $89
Nov-23-22Downgrade Oppenheimer Outperform → Perform $106 → $85
Nov-23-22Downgrade Citigroup Buy → Neutral $108 → $85
Nov-16-22Downgrade Deutsche Bank Buy → Hold $85
Oct-18-22Initiated Barclays Equal Weight $90
May-24-24 10:00AM
May-23-24 02:00PM
01:38PM
01:14PM
11:50AM
11:03AM Loading…
11:03AM
10:52AM
10:36AM
09:30AM
08:13AM
07:55AM
07:52AM
07:10AM
07:02AM
06:52AM
06:45AM Loading…
06:45AM
06:00AM
May-22-24 09:06AM
May-21-24 03:04PM
01:24AM
May-20-24 04:22PM
10:54AM
10:52AM
09:57AM
09:15AM
08:31AM
06:51AM
06:12AM
May-19-24 08:09AM
08:00AM
04:31PM Loading…
May-17-24 04:31PM
11:35AM
09:00AM
May-16-24 08:00AM
May-14-24 04:44PM
12:00PM
11:19AM
08:21AM
May-13-24 05:50PM
04:58PM
12:10PM
May-11-24 07:11AM
May-10-24 12:45PM
09:10AM
May-09-24 12:51PM
10:00AM
09:00AM
08:45AM
07:00AM
May-08-24 12:15PM
May-07-24 06:22AM
May-06-24 10:50PM
05:50PM
12:00PM
09:00AM
May-04-24 10:26AM
May-03-24 10:41AM
09:03AM
08:30AM
May-02-24 03:18PM
May-01-24 08:15AM
Apr-29-24 05:50PM
11:50AM
06:42AM
02:56AM
Apr-26-24 08:52AM
07:56AM
Apr-25-24 11:34AM
Apr-24-24 09:00AM
06:54AM
Apr-23-24 01:38PM
06:14AM
Apr-22-24 05:50PM
Apr-19-24 10:45AM
Apr-18-24 11:09AM
09:05AM
08:40AM
Apr-17-24 07:02AM
Apr-16-24 05:50PM
05:40PM
04:55AM
Apr-15-24 07:35AM
Apr-13-24 12:18PM
Apr-12-24 09:00AM
08:00AM
Apr-11-24 09:17PM
09:31AM
06:15AM
06:05AM
Apr-10-24 05:50PM
09:27AM
08:45AM
08:30AM
Apr-09-24 08:33PM
Apr-08-24 10:15AM
08:00AM
01:53AM
Apr-07-24 09:45AM
08:00AM
Apr-04-24 05:50PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marinaro MichaelEVP & President, Surgical OUApr 08 '24Sale83.1485471,00227,925Apr 09 04:08 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Option Exercise69.0730,6952,120,12178,984Feb 23 05:18 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Sale85.1330,6952,613,05548,289Feb 23 05:18 PM
Wall Brett A.EVP & Pres NeuroscienceDec 19 '23Sale82.174,997410,60328,910Dec 20 11:41 AM
Smith Gregory LEVP Global Ops & Supply ChainAug 23 '23Sale83.8410,000838,40046,723Aug 25 03:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 14 '23Sale83.381,00083,38033,573Aug 16 05:16 PM
Marinaro MichaelEVP & President, Surgical OUAug 04 '23Sale84.111,352113,71728,930Aug 07 08:47 PM
Wall Brett A.EVP & Pres NeuroscienceJul 14 '23Sale87.972,000175,94023,948Jul 18 04:16 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Option Exercise55.325,514305,03447,508Jul 12 03:48 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Sale86.585,514477,42043,802Jul 12 03:48 PM